Why the study?
Does iFR-guided coronary revascularization prevent major adverse cardiac events at 1 year as effectively as FFR-guided revascularization in patients undergoing PCI?
Does iFR-guided coronary revascularization prevent major adverse cardiac events at 1 year as effectively as FFR-guided revascularization in patients undergoing PCI?
Answers are grounded in this paper and cite their sources.
iFR-guided PCI is noninferior to FFR-guided PCI for 1-year major adverse cardiac events, while offering shorter procedural times and fewer adverse procedural symptoms.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Davies et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: